Background S100A12 is related to acute brain injury and inflammation. We investigated the
clinical prognostic value of serum S100A12 in patients with severe traumatic brain injury …

Background Serum S100B was suggested to be elevated after brain damage in previous
studies. Nowadays, increasing evidence has revealed S100B was also elevated in other …

Objective To analyze the dynamic change of serum protein S100b in patients with traumatic
brain injury and its clinical value in assessing brain damage. Methods According to Glasgow …

As an astrocytic protein specific to the central nervous system, S100b is a potentially useful
marker in outcome prediction after traumatic brain injury (TBI). Some studies have …

Background: Severe traumatic brain injury (TBI) is associated with a 30%–70% mortality
rate. S100B has been proposed as a biomarker for indicating outcome after TBI …

Introduction Patients suffering from severe traumatic brain injury (TBI) often develop
secondary brain lesions that may worsen outcome. S100B, a biomarker of brain damage …

S100B is a calcium-binding protein released into the blood from astroglial cells due to brain
injury. Some authors have described a correlation between S100B serum concentration and …

Primary objectives: To examine the diagnostic value of S100 in mild traumatic brain injury
(MTBI). Research design: Prospective cohort study. Methods and procedures: S100B …

Background Protein S100B has proven to be a useful biomarker for cerebral damage. The
predictive ability of S100B may, however, be affected by extracerebral injuries. The aim of …

Background S100A12 is implicated in inflammatory reactions. The purpose of this study was
to determine the association between serum S100A12 concentrations and 30-day mortality …